[Diffuse nodular pulmonary opacities in a HIV positive patient].

Rev Pneumol Clin

Service de Pneumologie, Hôpital Tenon, Paris.

Published: August 1991

Download full-text PDF

Source

Publication Analysis

Top Keywords

[diffuse nodular
4
nodular pulmonary
4
pulmonary opacities
4
opacities hiv
4
hiv positive
4
positive patient]
4
[diffuse
1
pulmonary
1
opacities
1
hiv
1

Similar Publications

Hypercalcaemia in association with Sertoli cell tumour in a dog.

J Small Anim Pract

January 2025

Department of Veterinary Medicine and Surgery, University of Missouri, College of Veterinary Medicine, Columbia, Missouri, USA.

A 9-year-old, presumed male castrated mixed breed dog was evaluated for lethargy, hyporexia, polyuria, polydipsia and diffuse gynaecomastia. Bloodwork revealed severe hypercalcaemia and hyposthenuria. CT scan showed a caudal abdominal mass consistent with a Sertoli cell tumour on cytology.

View Article and Find Full Text PDF

Objective: To investigate the clinical and ultrasound features of fibrous pseudotumor of tunica vaginalis of the testis.

Methods: The clinical and ultrasound features of fibrous pseudotumor of the tunica vaginalis diagnosed by pathology in West China Hospital of Sichuan University from 2006 to 2023 were retrospectively analyzed.

Results: The study included 8 patients diagnosed with fibrous pseudotumor of the tunica vaginalis.

View Article and Find Full Text PDF

Purposes: Immunoglobulin G4-related disease (IgG4-RD) and plasma cell-type idiopathic multicentric Castleman disease (PC-iMCD) have many overlapping features. Their differential diagnosis is challenging and crucial for clinical management due to their different prognoses and treatments. However, reports that compare these conditions are scarce, especially for patients with lung involvement.

View Article and Find Full Text PDF

BACKGROUND Simultaneously occuring diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL) is extremely rare. Generally, patients with CD20-positive DLBCL receive rituximab, cyclophosphamide, vincristine, doxorubicin, prednisone (R-CHOP) regimen, while those with HL receive brentuximab vedotin, doxorubicin, vinblastine, dacarbazine (A-AVD) regimen as first-line therapy. Establishing a strategy for treating both lymphoma subtypes concurrently is thus very difficult.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!